Saudi Arabia Animal Biotechnology Market By Product (Diagnostics, Biologics, Drugs, Nutrition, Others), By Animal Type (Dogs, Cats, Horses, Poultry, Swine, Cattle, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

Saudi Arabia Animal Biotechnology Market was valued at USD 75.84 Million in 2024 and is expected to reach USD 92.16 Million by 2030 with a CAGR of 3.50% during the forecast period. The Saudi Arabia Animal Biotechnology Market is experiencing significant growth, driven by increasing demand for innovative solutions in the agricultural and veterinary sectors. Animal biotechnology, which involves the application of scientific and technological advancements to improve livestock health, breeding, and productivity, is gaining traction in the country due to its potential to enhance food security and sustainability.

A key factor contributing to the expansion of the market is the rising need for advanced biotechnological tools to address challenges such as disease outbreaks and the need for efficient livestock management. Genetic engineering, molecular diagnostics, and reproductive technologies are some of the prominent innovations transforming the industry. These technologies allow for the development of healthier and more resilient animals, reducing the risk of disease transmission and improving overall livestock performance.

As the market continues to evolve, it presents numerous opportunities for companies involved in animal biotechnology to introduce innovative products and services that address the specific needs of the Saudi livestock industry. Collaborations between local and international stakeholders are expected to further enhance the development and adoption of cutting-edge biotechnological solutions, positioning Saudi Arabia as a key player in the global animal biotechnology landscape.

Key Market Drivers

Growth in Healthcare Industry

The growth of the healthcare industry is emerging as a significant driver of the Saudi Arabia animal biotechnology market. The Healthcare Sector Transformation Program is revolutionizing the Kingdom's healthcare system, making it more comprehensive, efficient, and integrated than ever. This upgraded system emphasizes innovation, financial sustainability, and disease prevention, while enhancing access to healthcare services. It also aims to expand e-health services and digital solutions, improve the quality of care, and ensure compliance with international standards. With the increasing focus on healthcare innovation and the rising demand for advanced therapeutic solutions, the application of animal biotechnology in Saudi Arabia has gained substantial momentum. The country's healthcare sector is expanding rapidly, driven by government initiatives, higher healthcare spending, and a growing population, which in turn is fostering developments in biotechnology.

Animal biotechnology plays a crucial role in various healthcare-related applications, including the production of vaccines, therapeutic proteins, and diagnostic tools. These biotechnological advancements, derived from animal models, are being increasingly integrated into healthcare research and development (R&D) processes. The rise of zoonotic diseases and the need for more effective vaccines have further emphasized the importance of biotechnological innovations in healthcare. Rabies is an almost universally fatal zoonotic disease belonging to the Lyssavirus genus of the RNA family Rhabdoviridae. In Saudi Arabia, rabies is recognized as an endemic viral infectious disease among animals. Recent scientific data on rabies cases in camels from the Al-Qassim region, one of the Kingdom's thirteen administrative regions, indicate a rising incidence of this deadly virus. In Saudi Arabia, these advancements align with the Vision 2030 initiative, which seeks to diversify the economy and promote the local production of cutting-edge medical technologies.

Surge in Technological Advancements

The surge in technological advancements is playing a pivotal role in driving the growth of the animal biotechnology market in Saudi Arabia. As the Kingdom continues its efforts to diversify its economy and enhance the capabilities of its agricultural and livestock sectors, cutting-edge technologies are becoming integral to optimizing production and improving animal health. In March 2022, KAUST has announced a collaboration with the Ministry of Environment, Water, and Agriculture (MEWA) to launch the “Development of Algal Biotechnology in the Kingdom of Saudi Arabia” (DABKSA) initiative. The project aims to develop cutting-edge technologies for producing animal feed to support the agriculture sector in Saudi Arabia. Overseen by MEWA’s National Fisheries Development Program (NFDP) and hosted at the KAUST campus, the initiative is designed to establish a sustainable feed industry in the Kingdom, while also opening new economic opportunities in the aquaculture industry. Innovations in genetic engineering, molecular diagnostics, and reproductive technologies have revolutionized the sector, enabling the development of enhanced animal breeds with improved disease resistance, higher productivity, and better adaptability to the region’s climatic conditions.

Moreover, advancements in animal genomics and precision farming technologies are providing farmers with critical insights into animal behavior, health, and performance, thereby improving decision-making and reducing costs. The integration of artificial intelligence (AI) and Internet of Things (IoT) technologies is further streamlining operations, allowing for real-time monitoring of livestock and rapid identification of health concerns. This proactive approach not only enhances animal welfare but also contributes to the sustainability of the sector by reducing the reliance on antibiotics and other medical interventions.

Download Free Sample Report

Key Market Challenges

Lack of Skilled Workforce

A significant challenge facing the animal biotechnology market in Saudi Arabia is the lack of a skilled workforce. As the industry evolves with advanced technologies and innovative practices, there is a growing demand for specialized professionals with expertise in areas such as genetic engineering, molecular biology, and bioinformatics. However, the current talent pool in the Kingdom is limited, creating a skills gap that hinders the industry's growth.

This shortage of qualified professionals impacts both the development and implementation of cutting-edge biotechnology solutions. Companies may struggle to find the expertise needed to drive innovation, research, and product development, slowing the progress of critical projects. Additionally, the need for a robust skilled workforce can lead to an increased reliance on international talent, which may inflate operational costs and create dependency on external resources.

Key Market Trends

Increased Focus on Animal Health and Disease Prevention

The rising focus on animal health and disease prevention has become a significant trend driving the growth of Saudi Arabia’s animal biotechnology market. As the country continues to develop its agricultural and livestock sectors, there is an increasing recognition of the need to improve animal health, productivity, and welfare. This shift is being fueled by both government initiatives and growing private sector investments aimed at safeguarding animal populations and ensuring the sustainability of food production.

Rabies virus is regarded as an endemic viral infectious disease among animals in Saudi Arabia. Recent scientific data on rabies cases reported in camels from the Al-Qassim region (one of the thirteen administrative regions of Saudi Arabia) indicate a concerning rise in the number of cases of this fatal viral disease. One of the key factors contributing to this trend is the growing awareness of the economic impact of animal diseases. Outbreaks of infectious diseases in livestock can lead to significant financial losses due to decreased productivity, increased veterinary costs, and trade restrictions. As a result, there is a heightened demand for biotechnological solutions such as advanced vaccines, diagnostics, and genetic technologies that can prevent the spread of diseases and improve the overall health of animal populations.

Segmental Insights

Product Insights

Based on Product, Diagnostics have emerged as the fastest growing segment in the Saudi Arabia Animal Biotechnology Market in 2024. One of the primary drivers is the increasing demand for advanced diagnostic tools to ensure animal health and prevent the spread of diseases. As the livestock and aquaculture sectors expand in response to rising food security needs, the importance of early and accurate detection of diseases has become paramount. Additionally, the growing focus on improving livestock productivity has further fueled the demand for diagnostics. With enhanced diagnostics, farmers and veterinarians can make informed decisions on disease management, resulting in better animal health outcomes and higher yields.

Animal Type Insights

Based on Animal Type, Dogs have emerged as the fastest growing segment in the Saudi Arabia Animal Biotechnology Market during the forecast period. One of the primary drivers is the growing pet ownership trend in Saudi Arabia, particularly in urban areas where dogs are becoming increasingly popular as companions. As more households, particularly among the younger and expatriate populations, adopt dogs, there is rising demand for advanced healthcare solutions, including biotechnology-based products such as vaccines, diagnostics, and treatments for common canine diseases. This has fueled growth in the biotechnology sector, with a focus on enhancing the health and welfare of dogs.

Download Free Sample Report

Regional Insights

Based on Region, Northern & Central have emerged as the dominating region in the Saudi Arabia Animal Biotechnology Market in 2024. The Northern and Central regions are home to some of the largest agricultural and livestock operations in Saudi Arabia. These areas are crucial for livestock farming, which is a significant contributor to the country's agriculture sector. As a result, there is a high demand for advanced biotechnology solutions to enhance animal health, productivity, and breeding practices in these regions. Key research institutions and universities focused on biotechnology are located in these regions. These institutions are driving advancements in animal genomics, vaccine development, and genetic engineering, making Northern and Central Saudi Arabia the epicenters of innovation and research in the field of animal biotechnology.

Recent Development

• In 2024, Saudi Arabia introduced a national biotech strategy aimed at becoming a global biotech hub over the next 16 years. This initiative is a key component of the broader Vision 2030 project, which seeks to position the nation as a biotech leader in the Middle East and North Africa region by 2030. In response to the COVID-19 pandemic, Saudi Arabia is focusing on developing new vaccine technologies, prioritizing advanced manufacturing capabilities, and building local bio-manufacturing platforms. Strengthening its biotech sector is expected to enhance domestic production, create jobs, and drive significant economic growth and diversification across multiple industries.
• According to a 2024 report by Nikkei Asia, Japan's SBI Holdings is set to launch its first biotechnology-focused investment in Saudi Arabia by the first half of 2025, as part of its international expansion strategy. The financial services group has secured an agreement with Saudi Arabia's Ministry of Investment and other key stakeholders to establish the fund, which is expected to manage assets ranging between USD 50 million and USD 100 million. The new fund will be co-managed with Saudi-based BIM Ventures, raising capital from foreign sovereign wealth funds and other investors. It aims to collaborate with the Saudi government to develop the domestic biotech industry and attract prominent global players.
• In 2025, the Deputy Minister of Environment launched the Artificial Intelligence Platform for Animal Health at the “LEAP 2025” Conference in Saudi Arabia. The ministry stated that the AI Platform for Animal Health is an innovative system leveraging artificial intelligence to analyze veterinary data, offering insights into veterinary visits, infections, and fatalities. It also predicts animal disease cases through veterinary clinics. The platform is designed to support decision-makers by improving veterinary care, raising health awareness, reducing infections and fatalities among animals, and enhancing veterinary service efficiency. Additionally, the ministry emphasized that the platform's launch at LEAP aligns with its digital transformation strategy, which advocates the integration of emerging and advanced technologies within the environment, water, and agriculture sectors.
• In 2024, a Saudi delegation from the Ministry of Environment, Water, and Agriculture (MEWA) explored collaborative opportunities with BIOTEC to drive innovations in aquaculture and livestock sectors. The discussions highlighted potential areas of cooperation, such as the development of vaccines for aquaculture and livestock, microbiome research related to disease control, and the use of biofilm inhibitors and probiotics to prevent bacterial diseases in aquatic species. MEWA, through its National Aquaculture Group (NAQUA), is already working with BIOTEC on a large-scale project aimed at understanding viral accommodation mechanisms and selecting shrimp stocks tolerant to white spot syndrome virus, as part of a joint breeding program between BIOTEC and NAQUA.

Key Market Players

• Saudi MAS Veterinary Services Company
• Biogénesis Bagó S.A.
• ALEMAR International
• Animal Nation KSA
• MONTAJAT VETERINARY PHARMACEUTICALS CO. LTD

Report Scope

In this report, the Saudi Arabia Animal Biotechnology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Saudi Arabia Animal Biotechnology Market, By Product:

o   Diagnostics

o   Biologics

o   Drugs

o   Nutrition

o   Others

• Saudi Arabia Animal Biotechnology Market, By Animal Type:

o   Dogs

o   Cats

o   Horses

o   Poultry

o   Swine

o   Cattle

o   Others

• Saudi Arabia Animal Biotechnology Market, By Region:

o   Eastern

o   Western

o   Northern & Central

o   Southern

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Saudi Arabia Animal Biotechnology Market.

Available Customizations:

Saudi Arabia Animal Biotechnology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Saudi Arabia Animal Biotechnology Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com